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among these would be polymerizing
actin at the neck of a budding vesicle
or tubule and forcing it away from the
plasma membrane. However, actin
polymerization is not universally ob-
served during the budding of clathrin
vesicles, and actin depolymerization
does not shut down all of endocytosis.
A simple explanation for the lack of
a uniform requirement for actin for
the formation of endocytic vesicles
might be that cells have developed
multiple mechanisms to form and
fission off endocytic carriers. The re-
quirement for amechanism using actin
might be dependent upon whether or
not actin and actin regulatory proteins
like N-WASP are locally abundant.
One can imagine that in locations
(such as the adherent plasma mem-
brane) where a dense cortical network
is in the way of membrane deformation
and movement, a rearrangement of
the actin cytoskeletonmight be neces-
sary and has been adapted to move
membrane carriers through the ob-
struction by using its own com-
ponents. At other locations where an
actin cytoskeleton is less abundant,
a mechanism using actin might not
be required. Since the actin cytoskele-
ton is dynamic and sensitive to growth
states, the requirement for actin in en-
docytosis could vary for the same cell
type under different growth condi-
tions, and might even vary at different
locations in the same cell.
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Classically, ubiquitination requires three enzymes acting in sequence: E1, E2, and E3. E3 ubiquitin
ligases typically provide substrate specificity. An article in Molecular Cell (Hoeller et al., 2007) now
describes the E3-independent monoubiquitination of certain proteins. The mechanism has interest-
ing parallels to SUMO ligation.Ubiquitin covalently modifies other
proteins, either as ubiquitin chains
(polyubiquitination) or single ubiquitin
moieties (monoubiquitination) (Ker-
scher et al., 2006). Attachment of
ubiquitin to a protein enhances its
interaction with ubiquitin receptors
containing ubiquitin-binding domains
(UBDs). The consequences of such in-
teractions depend on their timing and
cellular location and on the type of
ubiquitin modification. Generally, a
lysine in the substrate is coupled to
the C-terminal glycine of ubiquitin by
an amide (isopeptide) bond. This re-
quires prior activation of the ubiquitin
C terminus by E1, after which the4 Developmental Cell 13, July 2007 ª200ubiquitin is passed to an active site
cysteine side chain in an E2, creating
a thioester-linked E2-ubiquitin com-
plex. An additional factor, the E3 ubiq-
uitin ligase, is usually necessary for
efficient ubiquitin transfer from E2 to
substrate. E3 enzymes contain sub-
strate- and E2-binding domains and
may activate ubiquitin transfer by
the E2.
One area of cell regulation that
makes extensive use of monoubiquiti-
nation is endocytosis (Mukhopadhyay
and Riezman, 2007). Ubiquitin attach-
ment to plasma membrane proteins
usually causes their downregulation
by stimulating endocytosis and traf-7 Elsevier Inc.ficking to the lysosome for degrada-
tion. Additionally, multiple endocytic
adaptor proteins contain UBDs, which
allow them to modulate membrane
receptor trafficking by binding to the
ubiquitinated receptor or to other en-
docytic factors that have been ubiqui-
tinated. UBDs come in a variety of
structural flavors but have in common
the ability to bind ubiquitin noncova-
lently, usually with fairly low affinity
(Harper and Schulman, 2006). Inter-
estingly, many of the monoubiquiti-
nated endocytosis factors also bear
a UBD. Covalent monoubiquitination
of these proteins depends on the abil-
ity of the UBD to engage ubiquitin
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‘‘coupled monoubiquitination’’ (Woelk
et al., 2006).
The mechanism of coupled mono-
ubiquitination has been analyzed previ-
ously for two E3s, parkin and Nedd4,
which belong to different E3 structural
classes. Parkin is unusual in that it also
contains an N-terminal ubiquitin-like
domain, which is capable of binding
the UBD of the endocytic adaptor
Eps15. In the regulated endocytosis
of epidermal growth factor receptor
(EGF receptor), EGF stimulation trig-
gers receptor monoubiquitination and
the recruitment of Eps15. Parkin is
also recruited under these conditions,
and it binds to and is activated by
Eps15, leading to monoubiquitination
of the adaptor (Fallon et al., 2006).
This stimulates release of Eps15 from
the ubiquitinated EGF receptor by
switching it into a ‘‘closed’’ conforma-
tion caused by intramolecular ubiqui-
tin-UBD association (Hoeller et al.,
2006). The net result of parkin activa-
tion is enhancement of EGF signaling
at the plasma membrane due to
delayed receptor endocytosis.
Another E3 that can stimulate Eps15
monoubiquitination is Nedd4, which
forms a ubiquitin-thioester on its
HECT domain. A second ubiquitin is
attached to the E3 at another site
(Woelk et al., 2006). This second ubiq-
uitin binds the UBD in Eps15, facilitat-
ing transfer of the ubiquitin from the
HECT active site cysteine to a specific
Eps15 lysine. Together, these studies
indicate that either a ubiquitin-like do-
main built into the E3 or self-ubiquiti-
nation of the E3 can generate binding
sites for UBD-substrates, and these in-
teractions stimulate the ubiquitination
of the latter proteins.
Thus, it comes as something of
a surprise that Eps15 as well as other
UBD proteins can be monoubiquiti-
nated in vitro without any E3 ubiquitin
ligase at all, based on an article in the
current issue ofMolecular Cell (Hoeller
et al., 2007). At first blush, these obser-
vationswould not appear to be unusual
insofar as inefficient E3-independent
ubiquitination of proteins in vitro has
been seen since the early days of
ubiquitin analysis and has often been
dismissed as an in vitro artifact. How-
ever, in Hoeller et al. (2007) theE3-independent monoubiquitination
requires a functional UBD, which is-
knowntobephysiologically relevant for
coupled monoubiquitination in vivo.
Moreover, results of siRNAknockdown
and FRET experiments with trans-
fected tissue culture cells corroborate
the interaction of the ubiquitin-E2 con-
jugate with substrate and suggest that
neither this interaction nor the mono-
ubiquitination of UBD-substrate re-
quires an E3. Why E3-independent in
vitro monoubiquitination was not seen
in an earlier study (Woelk et al., 2006)
with the same Eps15 substrate and
cognate E2 is unclear.
Hoeller and colleagues checked
a battery of different E2s on an array
of different kinds of UBD-containing
proteins (Hoeller et al., 2007). All the
tested E2s can monoubiquitinate one
or another UBD protein, but efficiency
and specificity vary widely. Collec-
tively, the data suggest that
both UBD and non-UBD elements in
the substrates are important for
E2-ubiquitin binding and orientation.
The UBD proteins themselves do not
function as ordinary E3 ligases. They
promote their own ubiquitination—
acting as a kind of ‘‘cis ligase’’—but
they do not appear able to promote
transfer of ubiquitin to another protein
in trans.
While the new results from Hoeller
et al. (2007) will likely engender lively
discussion among those analyzing
ubiquitin conjugation, the story will
ring familiar to researchers studying
SUMO-protein ligation. Site-specific
E3-independent in vitro ligation of
substrates to SUMO, a ubiquitin-like
protein (Ubl), is commonplace. Nota-
bly, this usually requires relatively
high E2 concentrations, and the ques-
tion of full E3 independence in vivo
is unresolved. A noncovalent SUMO-
interacting motif (SIM) is also found in
many proteins, and in the same way
that ubiquitin-UBD interactions target
ubiquitinated proteins to specific
‘‘ubiquitin receptors,’’ noncovalent
SUMO-SIM binding directs sumoy-
lated proteins to SUMO receptors
(Kerscher et al., 2006). Moreover, cer-
tain SIM-bearing proteins are also
subject to covalent SUMO modifica-
tion, and noncovalent SIM-SUMO in-
teraction is sometimes a prerequisiteDevelopmentafor their sumoylation (‘‘coupled mono-
sumoylation’’) (Takahashi et al., 2005;
Lin et al., 2006). Crystallographic anal-
ysis (Baba et al., 2005) of one of these
sumoylated SIM proteins revealed an
intramolecular SIM-SUMO interaction
that might be analogous to the
autoinhibitory UBD-ubiquitin interac-
tion of endocytic factors (Hoeller
et al., 2006).
Combinations of covalent and non-
covalent Ubl associations in the
same polypeptide might be a broader
element of Ubl regulation than is cur-
rently appreciated. A recent study
found that the Ubl called Nedd8, which
covalently modifies cullin proteins,
also interacts noncovalently with a hy-
drophobic motif in the cullin (Wimutti-
suk and Singer, 2007). This latter inter-
action might be able to stimulate in
cis ligation of Nedd8 to the cullin as
well.
In summary, the report of E3-inde-
pendent monoubiquitination of pro-
teins carrying UBDs suggests deeper
mechanistic connections to the conju-
gation of other Ubls than previously
realized. Questions raised include how
exactly E3s stimulate coupled mono-
ubiquitination and how this process is
regulated. Hoeller et al. (2007) suggest
that E3-stimulated monoubiquitination
of endocytic adaptors occurs specifi-
cally when receptor signaling has
been activated. Whether constitutive
E3-independent monoubiquitination
of such factors is important for regulat-
ing endocytosis remains to be deter-
mined. If it is, then it may first need to
be reversed to bring the affected
adaptors into the active pool. Deubi-
quitinating enzymes would be key to
such mechanisms. We can look for-
ward to further developments on these
and related issues in the next few
years.
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The C. elegans male sex-determ
subunit of a Cullin-2 ubiquitin li
homolog and master regulator o
Sex determination is a fundamental
biological process involving a decep-
tively simple binary fate decision.
Studies over the last several decades
have revealed that diversity rules
when it comes to elucidating the mo-
lecular mechanisms underlying this
universal process.
In the nematode C. elegans, a chro-
mosomal counting mechanism gener-
ates the primary sex determining sig-
nal, the X:A ratio; XO animals develop
as males and XX animals as hermaph-
rodites (Figure 1) (Zarkower, 2005).
Downstreamgenesparticipate in a sig-
nal transduction pathway with simi-
larity to the Hedgehog (Hh) signaling
pathway (Kuwabara et al., 2000). Sig-
nificantly, the master regulator of sex
determination is the zinc finger tran-
scription factor, TRA-1 (Transformer-
1), which is the only C. elegans ortho-
log of Drosophila Ci and human Gli
proteins—terminal regulators of Hh
signaling. Genetic arguments posit
that TRA-1 promotes female or re-
presses male somatic development;
however, only repressive roles for
TRA-1 have been identified so far.
The primary mode of tra-1 regulation
is posttranscriptional (Zarkower and
Hodgkin, 1992). The tra-1 locus ex-
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ining protein, FEM-1, has been iden
gase complex. This complex contr
f sex determination, by ubiquitin-m
presses two isoforms: TRA-1A (Mr =
135 kDa) and TRA-1B (Mr = 37 kDa),
but only TRA-1A binds DNA (Schvarz-
stein and Spence, 2006; Zarkower
and Hodgkin, 1993). Like Drosophila Ci
(Jiang, 2002), proteolytic cleavage of
TRA-1A generates a range of C-termi-
nally truncated phosphoisoforms
(Mr = 90–110 kDa), which accumulate
only in feminized animals (Schvarz-
stein and Spence, 2006). In XO males,
the fem genes prevent the accumula-
tion of TRA-1A phosphoisoforms;
however, the domain architecture of
the FEM proteins has provided scant
clues to explain how this is achieved.
FEM-3 is a novel protein, FEM-1 car-
ries an ankyrin domain, and FEM-2 is
aphosphatase in searchof a substrate.
Importantly, inactivation of a single
fem gene is sufficient to feminize XO
animals inappropriately. So, just how
do the fem genes negatively regulate
tra-1?
In this issue of Developmental Cell,
Starostina and colleagues establish
that a Cullin-2 (CUL-2) ubiquitin ligase
complex is the missing player in this
long-standing puzzle (Starostina
et al., 2007). In the multisubunit CBC
(for CUL2, Elongin B, Elongin C) (E3)
ubiquitin ligase complex, CUL-2 asso-
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tified as a substrate recognition
ols the level of TRA-1A, a Ci/Gli
ediated proteolysis.
ciates with an Rbx1/Roc1 RING finger
protein at its C terminus and an Elongin
C adaptor at its N terminus. Elongin C
is also associated with Elongin B and
to a variable substrate recognition
subunit (SRS) (Kipreos, 2005). With
regard to sex determination, light
dawned when FEM-1 was uncovered
during a proteomic screen for CUL-2
interacting partners. Inspection of the
FEM-1 sequence revealed the pres-
ence of a VHL box, a domain mediat-
ing binding between the SRS and
Elongin C. Subsequently, a VHL-box-
dependent physical interaction be-
tween FEM-1 and Elongin C was
shown. Consistent with its proposed
role in reducing TRA-1 activity, a re-
duction in cul-2 activity produced par-
tially feminized XO intersexes and
suppressed the weak masculinization
phenotypes of XX tra-1 hypomorphs.
The complete elimination of cul-2
is lethal, which may explain why cul-2
was not found in genetic screens for
sexual transformation mutants. Once
it was established that FEM-1 could
function as an SRS subunit, it was
short work to demonstrate that
TRA-1A was the primary substrate tar-
geted for proteasomal degradation by
the CBCFEM-1 complex. Thus, cul-2
